Answers are grounded in this paper and cite their sources.
背景自家末梢血幹細胞採取でのplerixafor(PLX)の適正使用のために,動員不良リスク症例で採取前日末梢血CD34陽性細胞(PBCD34+)数が20/μl未満の場合にPLXを投与するアルゴリズム(PLX-A)を導入した.
No takes yet. Share an insight, caveat, or question.
Yamashita et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: